MedTrace Logo

Role of Fibirnogen Like Protein 2 as Aprognostic Factor in High Grade Glioma

NCT04113278 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1

Last updated 2019-10-02

No results posted yet for this study

Summary

The study population was selected from high grade glioma pateints attending the Department of Clinical Oncology, Assiut University hospital during the period from December 2018 to September 2020, we analyzed human high grade gliomas paraffin block for FLG2 expression

Conditions

  • Brain Tumor Adult

Interventions

GENETIC

FGL2 immunohisyochemistry

Correlation between FLG2 expression and progression free survival and overall surviv

Sponsors & Collaborators

  • sohaila Essam

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2020-09-01
Completion
2021-09-01

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04113278 on ClinicalTrials.gov